Literature DB >> 16565925

Plaques and tangles and the pathogenesis of Alzheimer's disease.

Richard A Armstrong1.   

Abstract

Since the earliest descriptions, senile plaques (SP) and neurofibrillary tangles (NFT) have been regarded as the pathological hallmarks of Alzheimer's disease (AD). Consequently, studies of the morphology, distribution, and molecular composition of SP and NFT have played an important role in developing theories as to the pathogenesis of AD; the most important being the 'Amyloid Cascade Hypothesis (ACH)'. Nevertheless, the significance of SP and NFT to the pathogenesis of AD remains controversial. This review examines three questions: 1) is there a relationship between the lesions and the degree of clinical dementia, 2) is the pathogenesis of the NFT linked to that of the SP, and 3) what is the relationship of SP and NFT to the pathogenesis of AD? These questions are discussed with reference to the morphology and molecular composition of SP and NFT, the effects of gene mutations, studies of head injury patients, experimental studies involving brain lesions and transgenes, and the degeneration of specific anatomical pathways. It was concluded that SP and NFT are not closely related to the developing dementia in AD, arise as relatively independent lesions, and may be the products of a degenerative process rather than being their cause.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565925

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  25 in total

1.  Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD).

Authors:  Walter J Lukiw
Journal:  Expert Opin Emerg Drugs       Date:  2012-03-23       Impact factor: 4.191

2.  Biochemical and morphological characterization of the AβPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease.

Authors:  Jesse M Hunter; William J Bowers; Chera L Maarouf; Michael A Mastrangelo; Ian D Daugs; Tyler A Kokjohn; Walter M Kalback; Dean C Luehrs; Jon Valla; Thomas G Beach; Alex E Roher
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Ligustrazine phosphate ethosomes for treatment of Alzheimer's disease, in vitro and in animal model studies.

Authors:  Jun Shi; Yiming Wang; Guoan Luo
Journal:  AAPS PharmSciTech       Date:  2012-03-14       Impact factor: 3.246

Review 4.  Neuropathology for the neuroradiologist: plaques and tangles.

Authors:  F J Wippold; N Cairns; K Vo; D M Holtzman; J C Morris
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-09       Impact factor: 3.825

5.  Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.

Authors:  Peter T Nelson; Erin L Abner; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Karen Santacruz; Charles D Smith; Ela Patel; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2009-07       Impact factor: 3.685

6.  Effect of melatonin and melatonylvalpromide on beta-amyloid and neurofilaments in N2a cells.

Authors:  Xiao-Chuan Wang; Yin-Chun Zhang; Nithiananda Chatterjie; Inge Grundke-Iqbal; Khalid Iqbal; Jian-Zhi Wang
Journal:  Neurochem Res       Date:  2008-01-31       Impact factor: 3.996

7.  Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice.

Authors:  Monica Garcia-Alloza; Laura A Borrelli; Bradley T Hyman; Brian J Bacskai
Journal:  Neurobiol Aging       Date:  2009-01-04       Impact factor: 4.673

8.  Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer's disease: a stochastic modelling approach.

Authors:  Carole J Proctor; Ilse Sanet Pienaar; Joanna L Elson; Thomas B L Kirkwood
Journal:  Mol Neurodegener       Date:  2012-07-02       Impact factor: 14.195

9.  Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer's disease.

Authors:  Umamon Puangthong; Ging-Yuek Robin Hsiung
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-02       Impact factor: 2.570

10.  Ligustrazine Attenuates Hyperhomocysteinemia-induced Alzheimer-like Pathologies in Rats.

Authors:  Qing Zhang; Jing Wang; Liang Zhu; Shi-Jie Jiang; Juan Liu; Lin-Xiao Wang; Xi-Hu Qin
Journal:  Curr Med Sci       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.